vs

Side-by-side financial comparison of Dow Inc. (DOW) and LyondellBasell (LYB). Click either name above to swap in a different company.

Dow Inc. is the larger business by last-quarter revenue ($9.5B vs $7.1B, roughly 1.3× LyondellBasell). On growth, Dow Inc. posted the faster year-over-year revenue change (-9.3% vs -25.3%). Over the past eight quarters, Dow Inc.'s revenue compounded faster (-6.9% CAGR vs -15.5%).

The Dow Chemical Company is an American multinational corporation headquartered in Midland, Michigan, United States. The company was among the three largest chemical producers in the world in 2021. It is the operating subsidiary of Dow Inc., a publicly traded holding company incorporated under Delaware law.

LyondellBasell Industries N.V. is an American multinational chemical company, incorporated in the Netherlands with U.S. operations headquartered in Houston, Texas and offices in London, UK. The company is the largest licensor of polyethylene and polypropylene technologies. It also produces ethylene, propylene, polyolefins, and oxyfuels.

DOW vs LYB — Head-to-Head

Bigger by revenue
DOW
DOW
1.3× larger
DOW
$9.5B
$7.1B
LYB
Growing faster (revenue YoY)
DOW
DOW
+16.0% gap
DOW
-9.3%
-25.3%
LYB
Faster 2-yr revenue CAGR
DOW
DOW
Annualised
DOW
-6.9%
-15.5%
LYB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DOW
DOW
LYB
LYB
Revenue
$9.5B
$7.1B
Net Profit
$-140.0M
Gross Margin
5.8%
4.7%
Operating Margin
-1.2%
Net Margin
-2.0%
Revenue YoY
-9.3%
-25.3%
Net Profit YoY
76.8%
EPS (diluted)
$-2.16
$-0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOW
DOW
LYB
LYB
Q1 26
$9.5B
Q4 25
$9.5B
$7.1B
Q3 25
$10.0B
$7.7B
Q2 25
$10.1B
$7.7B
Q1 25
$10.4B
$7.7B
Q4 24
$10.4B
$9.5B
Q3 24
$10.9B
$10.3B
Q2 24
$10.9B
$10.6B
Net Profit
DOW
DOW
LYB
LYB
Q1 26
Q4 25
$-1.5B
$-140.0M
Q3 25
$62.0M
$-890.0M
Q2 25
$-835.0M
$115.0M
Q1 25
$-307.0M
$177.0M
Q4 24
$-35.0M
$-603.0M
Q3 24
$214.0M
$573.0M
Q2 24
$439.0M
$924.0M
Gross Margin
DOW
DOW
LYB
LYB
Q1 26
5.8%
Q4 25
5.8%
4.7%
Q3 25
7.3%
11.7%
Q2 25
5.8%
10.3%
Q1 25
6.4%
7.2%
Q4 24
9.0%
7.9%
Q3 24
9.8%
12.0%
Q2 24
12.1%
13.4%
Operating Margin
DOW
DOW
LYB
LYB
Q1 26
Q4 25
-16.4%
-1.2%
Q3 25
0.7%
-9.5%
Q2 25
-6.5%
3.7%
Q1 25
-3.6%
1.5%
Q4 24
2.1%
-6.9%
Q3 24
3.0%
7.8%
Q2 24
5.6%
9.2%
Net Margin
DOW
DOW
LYB
LYB
Q1 26
Q4 25
-15.6%
-2.0%
Q3 25
0.6%
-11.5%
Q2 25
-8.3%
1.5%
Q1 25
-2.9%
2.3%
Q4 24
-0.3%
-6.3%
Q3 24
2.0%
5.6%
Q2 24
4.0%
8.8%
EPS (diluted)
DOW
DOW
LYB
LYB
Q1 26
$-2.16
Q4 25
$-2.16
$-0.45
Q3 25
$0.08
$-2.77
Q2 25
$-1.18
$0.34
Q1 25
$-0.44
$0.54
Q4 24
$-0.08
$-1.86
Q3 24
$0.30
$1.75
Q2 24
$0.62
$2.82

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOW
DOW
LYB
LYB
Cash + ST InvestmentsLiquidity on hand
$3.8B
$5.5B
Total DebtLower is stronger
$17.8B
$12.1B
Stockholders' EquityBook value
$16.0B
$10.1B
Total Assets
$58.5B
$34.0B
Debt / EquityLower = less leverage
1.12×
1.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOW
DOW
LYB
LYB
Q1 26
$3.8B
Q4 25
$3.8B
$5.5B
Q3 25
$4.6B
$2.5B
Q2 25
$2.4B
$2.5B
Q1 25
$1.5B
$3.0B
Q4 24
$2.2B
$6.0B
Q3 24
$2.9B
$4.3B
Q2 24
$3.3B
$4.7B
Total Debt
DOW
DOW
LYB
LYB
Q1 26
$17.8B
Q4 25
$17.8B
$12.1B
Q3 25
$17.7B
$10.6B
Q2 25
$16.2B
$11.2B
Q1 25
$15.9B
$10.6B
Q4 24
$15.7B
$10.5B
Q3 24
$16.2B
$11.1B
Q2 24
$16.0B
$11.0B
Stockholders' Equity
DOW
DOW
LYB
LYB
Q1 26
$16.0B
Q4 25
$16.0B
$10.1B
Q3 25
$17.5B
$10.6B
Q2 25
$17.2B
$11.9B
Q1 25
$16.8B
$12.2B
Q4 24
$17.4B
$12.5B
Q3 24
$18.3B
$13.7B
Q2 24
$18.3B
$13.4B
Total Assets
DOW
DOW
LYB
LYB
Q1 26
$58.5B
Q4 25
$58.5B
$34.0B
Q3 25
$61.0B
$33.8B
Q2 25
$59.0B
$35.4B
Q1 25
$57.5B
$35.2B
Q4 24
$57.3B
$35.7B
Q3 24
$59.4B
$37.3B
Q2 24
$58.5B
$37.1B
Debt / Equity
DOW
DOW
LYB
LYB
Q1 26
1.12×
Q4 25
1.12×
1.20×
Q3 25
1.01×
1.00×
Q2 25
0.94×
0.94×
Q1 25
0.95×
0.87×
Q4 24
0.91×
0.85×
Q3 24
0.88×
0.81×
Q2 24
0.87×
0.82×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOW
DOW
LYB
LYB
Operating Cash FlowLast quarter
$1.5B
Free Cash FlowOCF − Capex
$1.1B
FCF MarginFCF / Revenue
14.9%
Capex IntensityCapex / Revenue
6.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$384.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOW
DOW
LYB
LYB
Q1 26
Q4 25
$284.0M
$1.5B
Q3 25
$1.1B
$983.0M
Q2 25
$-470.0M
$351.0M
Q1 25
$91.0M
$-579.0M
Q4 24
$814.0M
$1.9B
Q3 24
$800.0M
$670.0M
Q2 24
$836.0M
$1.3B
Free Cash Flow
DOW
DOW
LYB
LYB
Q1 26
Q4 25
$-284.0M
$1.1B
Q3 25
$563.0M
$577.0M
Q2 25
$-1.1B
$-188.0M
Q1 25
$-594.0M
$-1.1B
Q4 24
$47.0M
$1.4B
Q3 24
$64.0M
$302.0M
Q2 24
$113.0M
$864.0M
FCF Margin
DOW
DOW
LYB
LYB
Q1 26
Q4 25
-3.0%
14.9%
Q3 25
5.6%
7.5%
Q2 25
-11.2%
-2.5%
Q1 25
-5.7%
-13.8%
Q4 24
0.5%
14.9%
Q3 24
0.6%
2.9%
Q2 24
1.0%
8.2%
Capex Intensity
DOW
DOW
LYB
LYB
Q1 26
Q4 25
6.0%
6.3%
Q3 25
5.7%
5.3%
Q2 25
6.6%
7.0%
Q1 25
6.6%
6.3%
Q4 24
7.4%
5.3%
Q3 24
6.8%
3.6%
Q2 24
6.6%
4.6%
Cash Conversion
DOW
DOW
LYB
LYB
Q1 26
Q4 25
Q3 25
18.18×
Q2 25
3.05×
Q1 25
-3.27×
Q4 24
Q3 24
3.74×
1.17×
Q2 24
1.90×
1.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOW
DOW

Segment breakdown not available.

LYB
LYB

Polypropylene$1.3B18%
Oxyfuels And Related Products$1.3B18%
Olefins And Co Products$1.1B15%
Advanced Polymer Solutions$774.0M11%
Po And Derivatives$497.0M7%
Other$492.0M7%
DE$440.0M6%
MX$353.0M5%
Intermediate Chemicals$341.0M5%
Discontinued Operations Disposed Of By Means Other Than Sale$265.0M4%
Other Products$199.0M3%
Related Party$126.0M2%

Related Comparisons